Jeffrey S. Parkin

Array ( [id] => 3802380 [patent_doc_number] => 05830641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies' [patent_app_type] => 1 [patent_app_number] => 8/214299 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 16770 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830641.pdf [firstpage_image] =>[orig_patent_app_number] => 214299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811368 [patent_doc_number] => 05709995 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses' [patent_app_type] => 1 [patent_app_number] => 8/214650 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19254 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/709/05709995.pdf [firstpage_image] =>[orig_patent_app_number] => 214650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580356 [patent_doc_number] => 05580739 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2' [patent_app_type] => 1 [patent_app_number] => 8/214221 [patent_app_country] => US [patent_app_date] => 1994-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 6400 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580739.pdf [firstpage_image] =>[orig_patent_app_number] => 214221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858698 [patent_doc_number] => 05705612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'NEF peptide encoded by human immunodefiency virus type 1 (HIV-1)' [patent_app_type] => 1 [patent_app_number] => 8/195024 [patent_app_country] => US [patent_app_date] => 1994-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 4220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705612.pdf [firstpage_image] =>[orig_patent_app_number] => 195024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725473 [patent_doc_number] => 05670309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Methods and diagnostic kits for the detections of HIV-2-specific antibodies employing polypeptides obtained from the simian immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/192782 [patent_app_country] => US [patent_app_date] => 1994-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 18216 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670309.pdf [firstpage_image] =>[orig_patent_app_number] => 192782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588873 [patent_doc_number] => 05567592 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal' [patent_app_type] => 1 [patent_app_number] => 8/190288 [patent_app_country] => US [patent_app_date] => 1994-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12878 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567592.pdf [firstpage_image] =>[orig_patent_app_number] => 190288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011369 [patent_doc_number] => 05889175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication' [patent_app_type] => 1 [patent_app_number] => 8/177145 [patent_app_country] => US [patent_app_date] => 1994-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8332 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 305 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889175.pdf [firstpage_image] =>[orig_patent_app_number] => 177145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073572 [patent_doc_number] => 06838236 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-04 [patent_title] => 'VPR function and activity' [patent_app_type] => utility [patent_app_number] => 08/167608 [patent_app_country] => US [patent_app_date] => 1993-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31681 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838236.pdf [firstpage_image] =>[orig_patent_app_number] => 08167608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 883683 [patent_doc_number] => 07351412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-01 [patent_title] => 'Cloned DNA sequences related to the genomic RNA of lymphadenopathy-associated-virus (LAV) and proteins encoded by said LAV genomic RNA' [patent_app_type] => utility [patent_app_number] => 08/156930 [patent_app_country] => US [patent_app_date] => 1993-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 4467 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351412.pdf [firstpage_image] =>[orig_patent_app_number] => 08156930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988864 [patent_doc_number] => 05891640 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it\'s use in immunodiagnostic assays' [patent_app_type] => 1 [patent_app_number] => 8/146028 [patent_app_country] => US [patent_app_date] => 1993-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 60 [patent_no_of_words] => 50875 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891640.pdf [firstpage_image] =>[orig_patent_app_number] => 146028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772265 [patent_doc_number] => 05773602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'DNA fragments obtained from a novel human immunodeficiency virus designated LAV.sub.MAL' [patent_app_type] => 1 [patent_app_number] => 8/154397 [patent_app_country] => US [patent_app_date] => 1993-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12385 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773602.pdf [firstpage_image] =>[orig_patent_app_number] => 154397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 162588 [patent_doc_number] => 07671038 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-03-02 [patent_title] => 'Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides' [patent_app_type] => utility [patent_app_number] => 08/131948 [patent_app_country] => US [patent_app_date] => 1993-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5287 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/671/07671038.pdf [firstpage_image] =>[orig_patent_app_number] => 08131948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3580893 [patent_doc_number] => 05580773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-03 [patent_title] => 'Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)' [patent_app_type] => 1 [patent_app_number] => 8/100118 [patent_app_country] => US [patent_app_date] => 1993-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 7639 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/580/05580773.pdf [firstpage_image] =>[orig_patent_app_number] => 100118 [rel_patent_id] =>[rel_patent_doc_number] =>)